An interventional study of Individual training using the Teach Back Method in Hemodialysis Patients, Teach Back and Depression, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-07-17.
Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care
Background: Depression is one of the most common psychiatric disorders among hemodialysis patients and is associated with increased morbidity and mortality. Due to the chronic nature of the disease and the burdens of treatment, patients often experience psychological distress. The Teach-Back Method is a patient education strategy that ensures comprehension and retention by having patients repeat the information in their own words, and has shown promise in managing chronic conditions.
Objective: This study aimed to evaluate the effect of individualized education using the Teach-Back Method on the depression levels of adult patients undergoing hemodialysis.
Methods: This was a two-center, randomized controlled interventional study with a pre-test-post-test design. A total of 40 patients with End-Stage Renal Disease (ESRD), aged between 18-65, who had been receiving hemodialysis for at least three months, were randomly assigned to intervention (n=20) and control (n=20) groups. The intervention group received three sessions of individualized education using the Teach-Back Method, while the control group received no intervention during the study. Depression levels were assessed using the Beck Depression Inventory (BDI) before and three months after the intervention.
Hypothesis
H1: Individual education provided using the Teach-Back Method reduces the level of depression in adult ESRD patients receiving hemodialysis treatment.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 40 is below the median of 84 across 6,720 interventional studies indexed under Depression.
Browse Depression studies →Saglik Bilimleri Universitesi is the lead sponsor of 430 studies on the registry; 137 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
They were asked to respond to the scale questions (post-test) 12 weeks after the pre-test and the first interview at the beginning of the study.
Pre-test was collected with patients receiving hemodialysis treatment. Individual training was given to the intervention group patients using the Tell What You Learned Method using face-to-face and individual interview techniques. The training was carried out in 3 sessions. After the training sessions were completed, they were asked to answer questions asked by the researcher in order to evaluate their knowledge, skills and behaviors regarding the Tell What You Learned Method. The intervention group patients were given a post-test in the third month (12th week) after the first interview.
Other: Individual training using the Teach Back Method
Day 1 (Monday): Patients are introduced to the study; consent forms are signed, and initial forms are completed. An educational booklet is provided and explained. General information about hemodialysis and treatment is delivered using the Teach-Back Method. Day 2 (Wednesday): Patients recall previous session topics; unclear points are clarified. Education focuses on fluid and dietary restrictions and the importance of adherence, using the Teach-Back Method. Day 3 (Friday): Patients summarize previous content; the researcher reinforces unclear areas. Education covers medication adherence and lifestyle habits, again using the Teach-Back Method.
Depression scores
Individual education given to adult ESRD patients receiving hemodialysis using the TeachBack Method reduces depression levels.
Time frame: For 12 weeks The intervention group consisted of patients who received hemodialysis treatment on Tuesdays, Thursdays, and Saturdays, and the control group consisted of patients who received treatment on Mondays, Wednesdays, and Fridays.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saglik Bilimleri Universitesi